VR Adviser as of Sept. 30, 2020
Portfolio Holdings for VR Adviser
VR Adviser holds 22 positions in its portfolio as reported in the September 2020 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Trillium Therapeutics, Inc. Cmn | 20.0 | $102M | 7.2M | 14.21 | |
| Constellation Pharmceticls I | 15.9 | $81M | 4.0M | 20.26 | |
| Altimmune (ALT) | 11.6 | $59M | 4.5M | 13.20 | |
| Athira Pharma (ATHA) | 5.5 | $28M | 1.5M | 18.46 | |
| Surface Oncology | 5.2 | $27M | 3.9M | 6.90 | |
| Keros Therapeutics (KROS) | 5.1 | $26M | 672k | 38.57 | |
| Relmada Therapeutics (RLMD) | 4.9 | $25M | 668k | 37.62 | |
| Humanigen | 4.9 | $25M | 2.3M | 10.64 | |
| Cardiff Oncology (CRDF) | 3.5 | $18M | 1.3M | 14.19 | |
| Imv | 3.5 | $18M | 4.0M | 4.44 | |
| Kura Oncology (KURA) | 3.4 | $18M | 575k | 30.64 | |
| Marinus Pharmaceuticals | 3.0 | $15M | 1.2M | 12.85 | |
| Celldex Therapeutics (CLDX) | 2.3 | $12M | 800k | 14.83 | |
| Metacrine Ord | 2.3 | $12M | 1.1M | 10.21 | |
| Alx Oncology Hldgs (ALXO) | 2.2 | $11M | 300k | 37.74 | |
| Unum Therapeutics Ord | 2.0 | $10M | 4.4M | 2.34 | |
| Syndax Pharmaceuticals (SNDX) | 1.8 | $9.2M | 626k | 14.76 | |
| Fs Development Corp-a Com Cl A | 1.1 | $5.6M | 500k | 11.20 | |
| Bctg Acquisition Corp | 1.0 | $5.2M | 500k | 10.36 | |
| Taysha Gene Therapies Com Shs (TSHA) | 0.5 | $2.6M | 108k | 24.06 | |
| Galera Therapeutics (GRTX) | 0.1 | $467k | 52k | 9.04 | |
| Medicenna Therapeutics Corp. (MDNAF) | 0.1 | $383k | 93k | 4.14 |
